OR signs of inflammation Flashcards

(38 cards)

1
Q

what is periosteal reaction

A

§ Periosteum lifted by inflammatory exudate
§ Stimulates osteoblasts to form new bone
§ Usually parallel layers- onion skin appearance
§ More typical in the mandible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the inflammatory lesions that can take place at the PA and the jaw

A

§ Periapical
□ Apical rarefying osteitis (ARO)
□ Condensing osteitis( apical sclerosing osteitis)
□ Mixed of ARO and Condensing osteitis
§ Jaw
□ Osteomyelitis
□ ORN
□ MRONJ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the hall mark features of PA lesion

A

associated with NV teeth

disruption of lamina dura, widening of PDL spaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what could widening PDL space be due to

A

§ Pulpal insult, TFO/attrition, iatrogenic, malignancy
○ Inflammatory exudate accumulates in PDL space
○ Clinical features
§ Can be asymptomatic or ttp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the radiographic description of periapical granuloma

A

§ Circumscribe, well defined radiolucent area of bone loss at apex ( apical rarefying osteitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the clinical symptoms of PA granuloma

A

○ Pulp necrosis, but usually asymptomatic
○ Little or no pain to percussion and palpation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is PA granuloma comprise of

A

○ Chronic inflammatory infiltrate of lymphocytes, histiocytes and plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the radiographic features of PA cyst

A

similar to PA granuloma, but larger in size >1cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the hiisto of PA cyst

A

○ Central cavity lined by stratified squamous epithelium, origin from the cell rests of Malassez

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the clinical features of acute apical abscess

A

§ Pulp necrosis
§ Ttp, ttPp
§ Severe pain, swelling, mobility
§ Elevation of tooth involved
§ In severe cases can have systemic symptoms like fever, facial swelling, lyphadenopathy, esp when pt is immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the radiographic description of acute apical absces

A

§ Loss of apical lamina dura
§ Resorption of apical bone
§ Appearance may vary
§ Could have diffused, ill defined radiolucency for more destructive inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the radiographic description of condensing osteitis

A

§ Diffuse radiopaque dense sclerotic bone around root of tooth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the clinical features of condensing osteitis

A

§ Occurs with pulpitis or pulp necrosis
§ Variable responses to vitality tests or percussion/palpation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is osteomyelitis

A

inflammation of the bone marrow not confined to localised area typically results in necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does osteomyelities typically occur

A

from pyogenic bacteria introduced via
§ Abscessed tooth
§ Surgery
§ Hematogenous spread

	○ Stimulates reaction involving cancellous and cortical bone and periosteum
	○ Can range from acute to chronic
		§ Acute
			□ Rapid onset, pain, swelling of adjacent soft tissues, fever, lymphadenopathy, leukocytosis
			□ Associated teeth mobile, ttP
			□ Can have purulent drainage
			□ Can have paresthesia of lower lip
		§ Chronic
			□ Sequalae of acute phase
				® Intermittent recurrent episodes of usually less severe swelling, pain, fever, lymphadenopathy, can have paresthesia and drainage with sinus formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where is the more common site for osteomyelitis

A

mandible» maxilla due to better blood vascularity for maxilla

17
Q

What type of pt would be at greater risk for osteomyelitis

A

greater risk
§ Systemic factors
□ Malnutrition, DM, leukemia, alcoholism
§ Disorders of decreased vascularity
□ Sickle cell anemia
□ osteoporosis
§ Immunosuppression
□ aids
§ On medication
□ Steroids, chemo, bisphosphonates
○ Related conditions to osteomyelitis
§ Chronic recurrent multifocal osteomyelitis (CRMO)
§ Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO)
§ Both occurs de novo without acute phase, without identifiable pathogenic microorganism

18
Q

what is the hallmark of osteomyelitis

19
Q

what is the radiographic description of osteomyelitis

A

Subtle decrease in bone trabeculation, increase in radiolucency, ill corticated

20
Q

how does chronic osteomyelitis appear radiographically

A

□ Sequestrum, ranges in size
Starts to appear sclerotic, moth eaten appearance, often mixed radiolucent and radiopaque internally

21
Q

what is the histopathology of osteomyelitis

A

§ Necrotic bone, loss of osteocytes from lacunae
§ Inflammatory infiltrate/soft tissue component
§ Predominantly neutrophils> mononuclear cells

22
Q

what is the management of osteomyelitis

A

§ Must remove source of infection
□ Curettage, sequestrectomy, decortication( remove poorly vascularised bone and placing vascular periosteum next to bone marrow to induce healing), resection
□ Antibiotic therapy only effective if bacterial cultures are positive

23
Q

what is osteoradionecrosis

A

presence of exposed bone for 3 months or more following radiotherapy

24
Q

what is the disease mechanism for ORN

A

○ Disease mechanism
§ Bone necrosis from high doses of radiation
§ Exaerbated by infections, dental extractions, dental trauma
§ Mandible» maxila due to blood supply difference

25
pathophysiology of ORN
§ Low doses stimulates osteoblasts, leading to bone formation § Intermediate doses causes osteoblast/chondroblast cell death § High doses damage mature intact bone § Radiotherapy also causes damage to endothelial cells in smaller vessels. □ Leads to bone hypoxia--> hypocellular and hypovascular bone
26
what is marx staging for ORN based on? how many stages are there
based on response to Hyperbaric oxygen therapy, 3 stages
27
what is the clinical features of ORN
§ Most common in posterior mandible( direction of radiotherapy beam) § Exposed bone may or may not have sequestration § Intermittent swelling § Extra oral damage May or may not have pain
28
what is the radiographic features of ORN
§ Similar to osteomyelitis but periosteal reaction is rare, because radiotherapy has killed off osteoblasts § Ill defined non corticated moth eaten, mixed. Sequestrum present
29
what is the management of ORN
□ Dental clearance prior to radiation therapy is crucial □ Preventive dental treatment ( maintaining OH, denture hygiene) □ Surgical intervention (curettage, decortication, sequestrectomy) Hyperbaric oxygen with antibiotics
30
what is MRONJ
○ Typically associated wiith anti resorptive medications used for § Cancer related conditions including hypercalcemia of malignancy § Complications from bone metasteses from breast, prostate and lung CA, such as spinal cord compression and pathologic fractures; bone pain § Multiple myeloma § Osteoporosis related fracture § Metabolic bone diseases like paget's disease, osteogenesis imperfecta § Others like giant cell tumour of bone, fibrous dysplasia § DRUG FOR BISPHOSPHONATES: □ ORAL: alendronate(fosamax), risedronate (actonel) □ IV: ibandronate (boniva), zoledronic acid (reclast)/ zolendronate(zometa) denosumab, romosozumab
31
what is aaoms criteria for MRONJ
§ Current or previous tx with anti resorptive therapy alone or in combination with immune modulators or antiangiogenic agents § Exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial regions that has persisted for more than 8 weeks No history of radiation therapy to jaws or metastatic disease to the jaws
32
what is stage 2 of MROnJ
□ Exposed and necrotic bone or fistula that probes to the bone in pt who are ® Symptomatic ® Have evidence of infection/inflammation May present with stage 0 radiographic findings localised to alveolar bone
33
what is stage 3 of mronj
□ Exposed and necrotic bone or fistula that probes to the bone in pt with ® Evidence of infection ® And one of the following ◊ Extra oral fistua ◊ Pathologic fracture ◊ Extra oral fistula ◊ Oro antral/oral nasal communication Osteoysis extending to inferior border of mandible or sinus floor
33
what is the pathophysiology of MRONJ
nhibition of bone remodelling □ Antiresorptive drugs inhibit osteoclast formation, differentiation and function--> decreased bone resorption and remodelling, causing delayed healing § Infection and inflammation □ Presence of inflammatory cytokines at MRONJ sites, poor OH and biofilm presence associated with development of MRONJ § Inhibition of angiogenesis □ Some bisphosphonates directly inhibit angiogenesis, decrease vascularity at MRONJ sites □ Antiangiogenic drugs associated with MRONJ § Innate or acquired immune dysfunction □ Patients with metastatic or primary bone CA, in immunocompromised states, or those on immune modulating drugs at higher risk for MRONJ
33
what are the risk factors for MRONJ
malignnacy those taking denosumba higher risk than bisphosphonate the longer the duration on antiresorptive, increased risk of MRONJ local factors like dentoalvelar ops mandible>>maxilla female higher prevelance
33
management strategies for MRONJ
§ Education about risks of MRONJ § Dental clearance prior to start of antiresorptive therapy especially when AR therapy indicated for malignant diseases § Identify sites of acute or potential infection § Remove teeth with poor prognosis § Continued preventive maintenance after start of AR therapy ( perio maintainence)
34
what are the risk of MRONJ pt
® Osteoporotic pt on BP --> 0-0.15% ® Osteoporotic pt on DMB--> 1% Cancer pt on BP--> 1.6-14.8%
35